BIO-GENE TECHNOLOGY LTD (BGT) — research page
AU · au-cm-kg/ASX/BGT · as of 2026-11-06
Identity and listing
BIO-GENE TECHNOLOGY LTD is listed on the ASX under ticker BGT. Its ISIN is AU000000BGT8 and its LEI is not on the record, the ISIN not appearing in the GLEIF ISIN-to-LEI mapping file. Its security type is Corporate, its segment is not on the record, its sector is Materials, and its jurisdiction is Australia (ASIC-registered public company). The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | BIO-GENE TECHNOLOGY LTD | source · 2026-11-06 |
| exchange | ASX | source · 2026-11-06 |
| ticker | BGT | source · 2026-11-06 |
| ISIN | AU000000BGT8 | source · 2026-11-06 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | Materials | source · 2026-11-06 |
| jurisdiction | Australia (ASIC-registered public company) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 58 filings across 40 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 6 days. The latest filing is dated 2026-10-30 and is of type agm_record_date, 7 days before the record date of 2026-11-06. The ASX peer median is 6 days cadence, 58 filings and 4.0 days latency across 1829 issuers. The Materials sector median is 5.5 days cadence, 61 filings and 3.0 days latency across 769 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 58 | 6 | 7 |
| exchange median: ASX (1829 issuers) | 58 | 6 | 4 |
| sector median: Materials (769 issuers) | 61 | 5.5 | 3 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-30 | agm_record_date | Notice of Annual General Meeting/Proxy Form | |
| 2026-10-30 | quarterly | Quarterly Activities/Appendix 4C Cash Flow Report | |
| 2026-10-28 | corporate_action | Proposed issue of securities - BGT | |
| 2026-10-12 | agm_record_date | Date of 2026 Annual General Meeting | |
| 2026-10-09 | newswire_release | Perceive Biotherapeutics Completes Enrollment in Phase 2a JOURNEY Study of VOY-101 Gene Therapy for Geographic Atrophy and Appoints Tony Gibney to Board of Directors |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Horizon Nexus (Audit) Pty Ltd, whose location is not on the record. Auditor changes are not on the record, as the market's lifecycle type map is not yet in place.
Events and halts
The record holds no delisting, domicile change, listing, name change or segment move for the issuer, as the market's lifecycle type map is not yet in place. The issuer is listed and not halted.
Orderability
The outcome for client categories is not determinable, because the chapter's orderability section carries no client categories and so cannot name its client category. The rule version is acm-68000/au/ddo-design-and-distribution-obligations/r1, with the chapter as of 2026-11-04.
rule acm-68000/au/ddo-design-and-distribution-obligations/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The field has not been read, so the number of research houses named on the issuer's investor-relations page is not on the record.
Open research
The field has not been read, so the number of openly published research notes on the record is not on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.asx.com.au/markets/trade-our-cash-market/directory (identity.exchange)
- 10.2
- https://www.asx.com.au/markets/company/BGT (identity.isin)
- 10.3
- https://data.gov.au/data/dataset/asic-companies (identity.jurisdiction)
- 10.4
- https://mcp.au-cm-kg.ai/events/ASX/BGT (the disclosure lines)
- 10.5
- https://asx.api.markitdigital.com/asx-research/1.0/markets/announcements ; https://www.nsx.com.au/marketdata/delisted-suspended/ (the halt flag)
- 10.6
- https://announcements.asx.com.au/asxpdf/20260828/pdf/073dk786whybhh.pdf (the auditor)
- 10.7
- https://mcp.au-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.au-cm-kg.ai/record/ASX/BGT (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"AU000000BGT8"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:7a40a9a9c7b13b3a.